Literature DB >> 510233

Asthma and respiratory irritants (ozone).

F Silverman.   

Abstract

Asthmatics appear to be more susceptible to the effects of air pollutants than nonasthmatics. The present studies were undertaken to examine the effects of exposing asthmatics to ozone concentrations that occur in the environment. Seventeen well-documented male and female asthmatics have been exposed for 2 hr in an environmental chamber to 0.25 ppm of ozone on one occasion (ozone) and to air on another occasion (air). Effects were assessed by measurements of pulmonary function obtained prior to (0 hr), every half-hour during and at the end of all exposures (2 hr). Paired t-test analysis of lung volumes, forced expiratory volume in 1 sec (FEV1.0), and maximum expiratory flow rates at 50% of vital capacity (V50%VC) showed no significant changes (p greater than 0.05) when the following comparisons were made: 0 hr air vs 0 hr ozone, 0 hr air vs. 2 hr air, 0 hr ozone vs. 2 hr ozone, 2 hr air vs. 2 hr ozone. There was variability in severity of asthma and pulmonary function status; most subjects were taking some form of medication at the time of study. Some asthmatics showed no change or improvement with both air and ozone and others developed greater reductions in pulmonary function with ozone than with air. Approximately one-third of the asthmatics demonstrated greater changes in V50%VC with exposure to 0.25 ppm of ozone relative to air exposure. These studies indicate that acute exposures to ozone at realistic concentrations in the environment can produce adverse responses in some asthmatics.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 510233      PMCID: PMC1637360          DOI: 10.1289/ehp.7929131

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  23 in total

1.  EFFECT OF LOW CONCENTRATIONS OF OZONE ON PULMONARY FUNCTION IN MAN.

Authors:  W A YOUNG; D B SHAW; D V BATES
Journal:  J Appl Physiol       Date:  1964-07       Impact factor: 3.531

2.  THE SIGNIFICANCE OF YOKOHAMA ASTHMA.

Authors:  M SPOTNITZ
Journal:  Am Rev Respir Dis       Date:  1965-09

3.  Variation in respiratory function in selected patients and its relation to air pollution.

Authors:  W S SPICER; P B STOREY; W K MORGAN; H D KERR; N E STANDIFORD
Journal:  Am Rev Respir Dis       Date:  1962-11

4.  The Nashville air pollution study. I. Sulfur dioxide and bronchial asthma. A preliminary report.

Authors:  L D ZEIDBERG; R A PRINDLE; E LANDAU
Journal:  Am Rev Respir Dis       Date:  1961-10

5.  Air pollution and asthmatic attacks in the Los Angeles area.

Authors:  C E SCHOETTLIN; E LANDAU
Journal:  Public Health Rep       Date:  1961-06       Impact factor: 2.792

6.  Respiratory function tests; normal values at median altitudes and the prediction of normal results.

Authors:  H I GOLDMAN; M R BECKLAKE
Journal:  Am Rev Tuberc       Date:  1959-04

7.  Pulmonary function changes in ozone-interaction of concentration and ventilation.

Authors:  F Silverman; L J Folinsbee; J Barnard; R J Shephard
Journal:  J Appl Physiol       Date:  1976-12       Impact factor: 3.531

8.  Adaptation to short-term respiratory effects of ozone in men exposed repeatedly.

Authors:  J D Hackney; W S Linn; J G Mohler; C R Collier
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-07

9.  "Tokyo-Yokohama asthma". The rapid development of respiratory distress presumably due to air pollution.

Authors:  H W PHELPS; S KOIKE
Journal:  Am Rev Respir Dis       Date:  1962-07

10.  Studies in adaption to ambient oxidant air pollution: effects of ozone exposure in Los Angeles residents vs. new arrivals.

Authors:  J D Hackney; W S Linn; R D Buckley; H J Hislop
Journal:  Environ Health Perspect       Date:  1976-12       Impact factor: 9.031

View more
  10 in total

1.  ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice.

Authors:  David I Kasahara; Joel A Mathews; Chan Y Park; Youngji Cho; Gabrielle Hunt; Allison P Wurmbrand; James K Liao; Stephanie A Shore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-14       Impact factor: 5.464

2.  Pulmonary inflammation induced by subacute ozone is augmented in adiponectin-deficient mice: role of IL-17A.

Authors:  David I Kasahara; Hye Y Kim; Alison S Williams; Norah G Verbout; Jennifer Tran; Huiqing Si; Allison P Wurmbrand; Jordan Jastrab; Christopher Hug; Dale T Umetsu; Stephanie A Shore
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

Review 3.  Effects of ozone exposure at ambient air pollution episode levels on exercise performance.

Authors:  W C Adams
Journal:  Sports Med       Date:  1987 Nov-Dec       Impact factor: 11.136

Review 4.  Photochemical air pollution. Part I.

Authors:  E Goldstein; J D Hackney; S N Rokaw
Journal:  West J Med       Date:  1985-03

5.  Exposure estimates in assessing helath effects of air pollution.

Authors:  F Silverman; L D Pengelly; S Mintz; A T Kerigan; H R Hosein; P Corey; C H Goldsmith
Journal:  Environ Monit Assess       Date:  1982-03       Impact factor: 2.513

6.  The interleukin-33 receptor contributes to pulmonary responses to ozone in male mice: role of the microbiome.

Authors:  David I Kasahara; Jeremy E Wilkinson; Youngji Cho; Aline P Cardoso; Curtis Huttenhower; Stephanie A Shore
Journal:  Respir Res       Date:  2019-08-27

7.  The role of ozone exposure in the epidemiology of asthma.

Authors:  J R Balmes
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

8.  Health risks from acid rain: a Canadian perspective.

Authors:  C A Franklin; R T Burnett; R J Paolini; M E Raizenne
Journal:  Environ Health Perspect       Date:  1985-11       Impact factor: 9.031

Review 9.  Effect of ozone on respiratory responses in subjects with asthma.

Authors:  J Q Koenig
Journal:  Environ Health Perspect       Date:  1995-03       Impact factor: 9.031

10.  Toxicity of environmental ozone exposure on mice olfactory bulbs, using Western blot technique.

Authors:  Samah Abd-Elrahim Batran
Journal:  Toxicol Rep       Date:  2020-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.